Quick Answer
Disc Medicine, Inc. reported Stockholders Equity of $739.83 million for fiscal year 2025.
Disc Medicine, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $739.83M | +66.8% |
| 2024 | $443.59M | +28.5% |
| 2023 | $345.12M | +95.4% |
| 2022 | $176.60M | +375.1% |
| 2021 | -$64.20M | -122.9% |
| 2020 | -$28.81M | -176.2% |
| 2019 | -$10.43M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $573.39M | +22.5% | -6.6% |
| June 30, 2025 | $614.16M | +25.6% | -7.0% |
| March 31, 2025 | $660.36M | +95.3% | +48.9% |
| December 31, 2024 | $443.59M | +28.5% | -5.2% |
| September 30, 2024 | $467.96M | +30.4% | -4.3% |
| June 30, 2024 | $488.83M | +31.7% | +44.6% |
| March 31, 2024 | $338.07M | +45.2% | -2.0% |
| December 31, 2023 | $345.12M | +95.4% | -3.9% |
- Disc Medicine, Inc. showed an increase of +66.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Disc Medicine, Inc.’s stockholders equity has grown by 7191.9% (from -$10.43 million to $739.83 million).
- The most recent figure is from Disc Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: